课题基金 / 基金详情

Improving MRSA control through simulation and surveillance

Improving MRSA control through simulation and surveillance
通过模拟和监测改善 MRSA 控制
批准号：
7749870
负责人：
MICHAEL A. RUBIN
金额：
$0.0万
依托单位：
VA SALT LAKE CITY HEALTHCARE SYSTEM
依托单位国家：
美国
项目类别：
财政年份：
2009
资助国家：
美国
项目状态：
已结题
起止时间：
2009-07-01 至 2012-06-30
来源：
https://reporter.nih.gov/project-details/7749870
关键词：
AddressAdmission activityAffectAlgorithmsClassificationCohort StudiesCommunitiesComplexComputer SimulationComputerized Medical RecordCost-Benefit AnalysisCosts and BenefitsDataEconomicsEffectivenessElectronicsEnvironmentEpidemiologic MethodsEpidemiologyEvaluationFutureHealthcare SystemsHospitalsInfectionInfection ControlInformaticsInpatientsInterventionInvestigationKnowledgeMethodsMindModelingNosocomial InfectionsOutcomePatientsPerformancePoliciesPopulationPrevalenceProcessRelative (related person)ResearchResearch PersonnelResistanceRisk EstimateSimulateSiteStaphylococcus aureusSystemTechniquesTestingTimeTrainingTranslational ResearchValidationVeteransWorkbasebiomedical informaticscostdesignelectronic datahigh riskimprovedinnovationinsightmethicillin resistant Staphylococcus aureusmodels and simulationnovelprospectiveresearch studyresponsesimulationsurveillance strategytooltransmission process

项目成果

MICHAEL A. RUBIN的其他基金

相关文献

期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Intermountain Program on Antibiotic Resistance and microbial Threats (IMPART)
  • 批准号：
    10646169
  • 项目类别：
  • 资助金额：
    $73.72万
  • 财政年份：
    2021
  • 负责人：
    MICHAEL A. RUBIN
  • 依托单位：
    UNIVERSITY OF UTAH
Intermountain Program on Antibiotic Resistance and microbial Threats (IMPART)
  • 批准号：
    10466713
  • 项目类别：
  • 资助金额：
    $26.08万
  • 财政年份：
    2021
  • 负责人：
    MICHAEL A. RUBIN
  • 依托单位：
    UNIVERSITY OF UTAH
Antimicrobial Use and Control of Clostridium difficile transmission and infection
Antimicrobial Use and Control of Clostridium difficile transmission and infection